Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Apple Inc. (AAPL), Valeant Pharmaceuticals Intl Inc (VRX) Among Steadfast Capital’s Top New Picks

Page 1 of 2

Robert PittsSteadfast Capital Management recently filed its 13F with the Securities and Exchange Commission (SEC). Steadfast Capital Management is a New York-based, employee-owned hedge fund with over $10 billion in assets under management (AUM). The fund’s latest 13F reveals that its public equity portfolio is worth $7.17 billion as of March 31, 2015 with almost 10% of it invested in Allergan PLC (NYSE:AGN) (formerly Actavis plc (NYSE:ACT)). 23% of the fund’s equity portfolio as of the reporting period iss constituted of stocks from the information technology space, while 20% consists of stocks from the healthcare sector. Moreover, during the first quarter the fund increased its stake in 30 companies, sold out 12 holding entirely, reduced its stake in 11 companies, and initiated a stake in 14 stocks. In this article we are going to focus on Steadfast’s top three of those 14 newly-initiated picks, which are Apple Inc. (NASDAQ:AAPL), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and JD.Com Inc(ADR)(NASDAQ: JD).

Valeant VRX  contact lenses women finger eye care vision medical

wavebreakmedia /

But before we proceed to dissecting Steadfast Capital Management’s top new picks, let’s take a minute to understand how investors can benefit from tracking hedge funds’ moves. We have been researching 13F filings of hedge funds over a period of the last 16 years, and our research revealed that in the period between 1999 and 2012, the 15 most popular small-cap picks among hedge funds often outperformed the overall market. The most popular stocks overall on the other hand (mostly made up of large-cap stocks) underperformed the S&P 500 by seven basis points during that period. That’s not all; since the start of forward testing in August 2012, Insider Monkey’s small-cap strategy has outperformed the S&P 500 ETF (SPY) by 80 percentage points, returning 135%.

Robert Pitts
Robert Pitts
Steadfast Capital Management

According to our research, Apple Inc. (NASDAQ:AAPL) was the second-most popular stock among hedge funds during the first quarter, so it isn’t a surprise that funds like Steadfast Capital Management were initiating stakes in the popular company. In Steadfast’s case, it bought almost 2.5 million shares during the quarter, which were valued at about $310 million as of March 31. Apple recently garnered a lot of media attention due to its tussle with singer Taylor Swift over not paying artists for streaming their songs through its newly-launched service Apple Music’s first 3-month free subscription. The issue was resolved later when Apple Inc. (NASDAQ:AAPL) put its foot down and agreed to pay the artists. Being the largest company in the world, almost all analysts on the Street cover the stock and most of them have a ‘Buy’ rating on it. While the Street has an average price target of $147.28 on the stock, legendary activist investor Carl Icahn feels the shares are currently worth $240, almost double where they are trading right now. As of March 31 Icahn’s Icahn Capital LP owns over 52 million shares in Apple Inc. (NASDAQ:AAPL), the largest position among the over 700 hedge funds we track.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!